Filter Results:
(1,144)
Show Results For
- All HBS Web
(1,144)
- People (1)
- News (319)
- Research (698)
- Events (5)
- Multimedia (14)
- Faculty Publications (410)
Show Results For
- All HBS Web
(1,144)
- People (1)
- News (319)
- Research (698)
- Events (5)
- Multimedia (14)
- Faculty Publications (410)
- Web
Buy Now, Pay Later: Credit and the Market Economy: The Rise of Credit Reporting
the Courts Credit and Information Technology Credit in a Consumer Society Research Links Credits “Credit is the vital air of the system of modern commerce. It has done more — a thousand times more — to... View Details
- June 2011 (Revised October 2013)
- Case
Gene Patents (A)
By: Richard Hamermesh, David Kiron and Phillip Andrews
In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues... View Details
Keywords: Courts and Trials; Patents; Genetics; Judgments; Science-Based Business; Biotechnology Industry; United States
Hamermesh, Richard, David Kiron, and Phillip Andrews. "Gene Patents (A)." Harvard Business School Case 811-089, June 2011. (Revised October 2013.)
- June 1984
- Case
Federal Trade Commission and the Shared Monopoly Case against the Ready-to-Eat Cereal Manufacturers
By: Thomas K. McCraw and Richard S. Tedlow
Keywords: Business and Government Relations; Monopoly; Courts and Trials; Food and Beverage Industry; United States
McCraw, Thomas K., and Richard S. Tedlow. "Federal Trade Commission and the Shared Monopoly Case against the Ready-to-Eat Cereal Manufacturers." Harvard Business School Case 384-265, June 1984.
- 2008
- Article
Entrepreneurial Ventures and Whole-body Donations: A Regional Perspective from the United States
By: Michel Anteby and Mikell Hyman
Human cadavers are crucial to medical science. While the debate on how to secure sufficient cadavers has focused primarily on donors' behaviors, procuring organizations' roles in increasing donations remain less explored. The United States offers a unique setting in... View Details
Keywords: Entrepreneurship; Behavior; Programs; Nonprofit Organizations; Business Ventures; Health Testing and Trials; Demand and Consumers; Supply Chain; For-Profit Firms; Organizations; Training; United States
Anteby, Michel, and Mikell Hyman. "Entrepreneurial Ventures and Whole-body Donations: A Regional Perspective from the United States." Social Science & Medicine 66, no. 4 (2008): 963–969.
- April 2017
- Article
The New Look of Deal Protection
By: Guhan Subramanian and Fernán Restrepo
Deal protection in mergers and acquisitions (M&A) evolves in response to Delaware case law and the business goals of acquirers and targets. We construct a new sample of M&A deals from 2003 to 2015 to identify four such areas of evolution in current transactional... View Details
Subramanian, Guhan, and Fernán Restrepo. "The New Look of Deal Protection." Stanford Law Review 69, no. 4 (April 2017): 1013–1074.
- 11 Nov 2015
- Working Paper Summaries
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules
- 2012
- Other Unpublished Work
Lost in the Clouds: The Impact of Copyright Scope on Investment in Cloud Computing Ventures
By: Josh Lerner and Greg Rafert
Our analysis seeks to understand the impact of changes in copyright scope on investment in new firms. We begin by analyzing the investment effects of the Cartoon Network, et al. v. Cablevision decision in the U.S. and court rulings in France and Germany on venture... View Details
Keywords: Technological Innovation; Venture Capital; Internet and the Web; Investment; Business Startups; Copyright; France; Germany; United States; European Union
Lerner, Josh, and Greg Rafert. "Lost in the Clouds: The Impact of Copyright Scope on Investment in Cloud Computing Ventures." 2012.
- 31 Jan 2020
- Video
Blavatnik Fellow Jayon Wang Propelling X-COR Therapeutics Forward
- 20 Feb 2013
- Research & Ideas
Big Deal: Reflections on the Megamerger of American and US Airways
selling assets, generating additional cash for the company and giving it more flexibility to restructure its operations. Under Section 363 of the Bankruptcy Code, assets can be sold by a court order, without... View Details
- Web
Rare Disease Day – Small Numbers, Big Challenges… and Big Opportunities - Blog: Health Supplement
Delivery Clinical Trials Health Care Innovation Public Health Hereditary Hemorrhagic Telangiectasia (HHT) . Not only a mouthful, but also very hard to spell and remember - a fitting name for a rare disease.... View Details
- 2021
- Working Paper
Venture Capital's 'Me Too' Moment
By: Sophie Calder-Wang, Paul A. Gompers and Patrick Sweeney
In this paper, we document the historically low rate of hiring of women in the venture capital sector. We find that the high-profile Ellen Pao v. Kleiner Perkins gender discrimination trial had dramatic treatment effects. In difference-in-differences regressions, we... View Details
Keywords: Gender Discrimination; Founders; Venture Capital; Selection and Staffing; Gender; Lawsuits and Litigation
Calder-Wang, Sophie, Paul A. Gompers, and Patrick Sweeney. "Venture Capital's 'Me Too' Moment." NBER Working Paper Series, No. 28679, April 2021.
- 19 Apr 2018
- Video
Nalagenetics Final Pitch New Venture Competition 2018 Business Track
- April 2014 (Revised July 2015)
- Case
Sanofi Pasteur: The Dengue Vaccine Dilemma
By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud
In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details
Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France
Rangan, V. Kasturi, David E. Bloom, Vincent Dessain, and Emilie Billaud. "Sanofi Pasteur: The Dengue Vaccine Dilemma." Harvard Business School Case 514-074, April 2014. (Revised July 2015.)
- Web
Women, Work, and the “M” Word - Blog: Health Supplement
Blog Blog Health Care and Life Science at HBS Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author Executive Education Author HBS Partners Author HBS Staff Author... View Details
- July 2005
- Background Note
Guth v. Loft: Synopsis
By: Lynn S. Paine and Christopher Bruner
Provides a brief overview of the Supreme Court of Delaware's opinion in the 1939 case of Guth v. Loft, a widely cited application of the "corporate opportunity doctrine." Explores the corporate law principles regulating when a corporate manager can or cannot take... View Details
Paine, Lynn S., and Christopher Bruner. "Guth v. Loft: Synopsis." Harvard Business School Background Note 306-015, July 2005.
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- January–February 2023
- Article
Data-Driven COVID-19 Vaccine Development for Janssen
By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan
The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details
Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry
Bertsimas, Dimitris, Michael Lingzhi Li, Xinggang Liu, Jennings Xu, and Najat Khan. "Data-Driven COVID-19 Vaccine Development for Janssen." INFORMS Journal on Applied Analytics 53, no. 1 (January–February 2023): 70–84.
- July 2006 (Revised July 2007)
- Case
C.K. Coolidge, Inc. (Abridged)
Coolidge (CKC), a chemical manufacturer, is being sued for patent infringement. The plaintiffs are the patent holder and its sole licensee, who is also a CKC competitor. An analyst at CKC has done a breakeven decision analysis from CKC's perspective, balancing going to... View Details
Keywords: Negotiation Preparation; Courts and Trials; Patents; Analysis; Decision Choices and Conditions; Lawsuits and Litigation; Chemical Industry
Hammond, John S. "C.K. Coolidge, Inc. (Abridged)." Harvard Business School Case 607-006, July 2006. (Revised July 2007.)
- 28 Oct 2024
- Op-Ed
Latino Voters Have Grown More Politically Divided. That’s Not Surprising.
vehicles—political parties fight for votes where they can get them. If a group of voters starts to grow, then both parties will court that group with campaign effort, messaging, and policy change. And, in... View Details